๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hangzhou
Clinical trial register · China

Clinical Trials in Hangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine373 Zhejiang University104 First Affiliated Hospital of Zhejiang University103 AstraZeneca76 Zhejiang Cancer Hospital63
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Hangzhou

1812 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor
NCT07707882Tenosynovial Giant Cell Tumor, Diffuse
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
84
Hangzhou
2027-10-01
Not yet open
Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome
NCT07691645HCC - Hepatocellular Carcinoma, Chinese Herbal Medicine, ICG (Indocyanine Green), Overall Survival (All-cause Mortality)
Xiang-Qian
Phase 2
120
Hangzhou
2027-09-01
Not yet open
Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support
NCT07751003COPD (Chronic Obstructive Pulmonary Disease), Acute Exacerbation of COPD, Hypercapnia
Sir Run Run Shaw Hospital
Not applicable
236
Zhengzhou, Changsha, Hangzhou, Wenling
2027-08-01
Not yet open
Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD
NCT07698223Diabetic Nephropathy
Chen Xiangmei
Phase 4
410
Beijing, Chongqing, Dalian, Shanghai, Hangzhou
2027-03-01
Not yet open
AI for Newborn Metabolic Screening
NCT07368504Inherited Metabolic Disorders
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
200,000
Hangzhou
2027-01-01
Not yet open
The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study
NCT05560373Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage
Wanbangde Pharmaceutical Group Co., LTD
Phase 4
60
Hangzhou
2026-12-31
Not yet open
Adaptive Digital Exercise Rehabilitation for Children After CHD Surgery
NCT07574463Congenital Heart Disease (CHD), Congenital Heart Disease in Children
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
130
Hangzhou
2026-12-30
Not yet open
Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A
NCT06136507Severe Hemophilia A
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Phase 3
76
Chongqing, Guangzhou, Guizhou, Hangzhou, Hefei, Nanjing, Qingdao, Shenzhen
2026-12-25
Not yet open
Comparison of the Effects of Needle Biopsy Tract Resection and Non-resection on Recurrence Rate in Patients With Primary Extremity Sarcoma
NCT07575724Primary, Sarcoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
3,300
Hangzhou
2026-12-01
Not yet open
A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Prevention: Rimegepant Versus Flunarizine Non-inferiority Study
NCT07751497Vestibular Migraine
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
400
Hangzhou
2026-12-01
Not yet open
A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems
NCT07790861Obesity, Overweight
Eli Lilly and Company
Phase 3
192
Chengdu, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Luoyang Shi, Nanchang
2026-12
Not yet open
Effects of Exercise Snacks on Physical Health and Cognitive Function in Individuals With Intellectual Disabilities
NCT07759232Intellectual Disability
University of Macau
Not applicable
24
Hangzhou
2026-11-16
By invitation
Study on the Efficacy and Safety of Different Doses of PEG-rhG-CSF for Primary Prevention of Febrile Neutropenia
NCT07829276Malignant Tumor
Zhejiang Provincial People's Hospital
Observational
350
Hangzhou
2026-11-01
Not yet open
Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer
NCT07781150Obesity, Overweight, Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I
Tongji Hospital
Phase 2
128
Zhengzhou, Wuhan, Changchun, Hangzhou, Shanghai, Tianjin
2026-11-01
Not yet open
Study of SGB-9768 in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT07796256PNH - Paroxysmal Nocturnal Hemoglobinuria
Suzhou Sanegene Bio Inc.
Phase 2
24
Tianjin, Hangzhou
2026-10-31
Not yet open
Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia
NCT07827521Chronic Limb-Threatening Ischemia, Diabetic Foot Ulcer, Infrapopliteal Arterial Occlusive Disease
First Affiliated Hospital of Wenzhou Medical University
Phase 4
180
Hangzhou, Taizhou, Wenzhou
2026-10-20
Recruiting
Belumosudil Versus Ruxolitinib for Steroid-Refractory or Breakthrough Hepatic cGVHD
NCT07794514Hematopoietic Stem Cell Transplantation (HSCT), cGVHD, Hepatic cGVHD, Belumosudil
First Affiliated Hospital of Zhejiang University
Not applicable
170
Hangzhou
2026-10-01
Not yet open
Study of CM583 in Healthy Participants
NCT07823764Healthy
Keymed Biosciences Co.Ltd
Phase 1
40
Hangzhou
2026-10
Not yet open
Early Lumbar Drainage for Intraventricular Hemorrhage
NCT07625449Intraventricular Hemorrhage, Cerebral Hemorrhage
Second Affiliated Hospital of Nanchang University
Not applicable
392
Fuzhou, Jinan, Taizhou, Changde, Dezhou, Ganzhou, Guiyang, Hangzhou
2026-10
Not yet open
Treatment Strategy for Patients With RA-ILD
NCT07643038Rheumatoid Arthritis Associated Interstitial Lung Disease
Chinese SLE Treatment And Research Group
Phase 4
204
Luoyang, Beijing, Changchun, Chongqing, Dalian, Handan, Hangzhou, Hefei
2026-09-20
Recruiting
Role of Radiotherapy in T1-T2N0M0 Glottic Carcinoma With Poor Differentiation
NCT07781098Early Stage Glottic Squamous Cell Carcinoma With Poor Differentiation
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
38
Hangzhou
2026-09-16
Recruiting
Role of Postoperative Radiotherapy in T1-T2N0M0 Glottic Carcinoma Involving the Anterior Commissure
NCT07781085Early Stage Glottic Squamous Cell Carcinoma Involving the Anterior Commissure
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
38
Hangzhou
2026-09-16
Recruiting
GMPA Versus PPI for Gastric Protection and aGVHD Risk
NCT07791849Hematopoietic Stem Cell Transplantation (HSCT), aGVHD, Infection, Mortality
First Affiliated Hospital of Zhejiang University
Not applicable
198
Hangzhou
2026-09-15
Not yet open
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
NCT07540988Interstitial Lung Diseases
Boehringer Ingelheim
Phase 3
466
Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Nanjing, Shanghai, Suzhou
2026-09-14
Not yet open
A Study of Outcomes in Chinese Patients Treated With Anifrolumab Who Have Active Mod-severe Systemic Lupus Erythematosus
NCT07751848Lupus Erythematosus, Systemic
AstraZeneca
Phase 3
417
Beijing, Bengbu, Changchun, Changsha, Chengdu, Guangdong Province, Guangzhou, Hangzhou
2026-09-04
Not yet open
Sphere-9 PAF China Study
NCT07789925Paroxysmal Atrial Fibrillation (PAF)
Medtronic Cardiac Ablation Solutions
Not applicable
180
Beijing, Chengdu, Guangzhou, Hangzhou, Nanjing, Shanghai, Shenyang, Tianjin
2026-09-02
Not yet open
AI-Assisted Novel rbcDNA Detection for Early Gastric Cancer Diagnosis
NCT07782294Gastric Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
542
Anyang, Hangzhou, Shanghai
2026-09-01
Not yet open
Study of SG301 for Renal AMR After Transplantation
NCT07764627Antibody Mediated Rejection
Hangzhou Sumgen Biotech Co., Ltd.
Phase 2
10
Guangzhou, Nanning, Zhengzhou, Changsha, Jinan, Chengdu, Hangzhou
2026-09-01
Not yet open
Platinum-Free Regimen in Nasopharyngeal Carcinoma
NCT07794488Nasopharyngeal Cancinoma (NPC)
Zhejiang Cancer Hospital
Phase 2
145
Hangzhou
2026-09-01
Recruiting
Electroacupuncture at ST36 for Reducing Postoperative Inflammation After Cardiac Surgery With Cardiopulmonary Bypass
NCT07795112Systemic Inflammatory Response Syndrome (SIRS), Cardiac Surgical Procedures, Postoperative Complications (Cardiopulmonary)
Sir Run Run Shaw Hospital
Not applicable
140
Hangzhou
2026-09-01
Not yet open
Acupuncture for Generalized Anxiety Disorder
NCT07798986Generalized Anxiety Disorder (GAD)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
120
Hangzhou
2026-09-01
Recruiting
A Phase Ib/II Exploratory Clinical Trial of Memory-Enhanced 7ร—19-THEMIS CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
NCT07788118Relapsed/Refractory Large B-cell Lymphoma (LBCL), Diffuse Large B-Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), Transforming Follicular Lymphoma (tFL)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
70
Hangzhou
2026-09-01
Not yet open
A Sequential Trial of Low-Dose Radiotherapy Followed by Concurrent Immunotherapy, Systemic Chemotherapy, and Intraperitoneal Perfusion in Gastric Cancer With Peritoneal Carcinomatosis
NCT07784413Gastric Cancer Peritoneal Metastasis (GCPM)
Zhejiang Cancer Hospital
Phase 2
40
Hangzhou
2026-09-01
Recruiting
Physician and Patient Preferences for Cell Therapies in Advanced Solid Tumors
NCT07813000Solid Tumors
Zhejiang University
Observational
1,020
Hangzhou
2026-09-01
Not yet open
A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant
NCT07613359Antibody-Mediated Rejection (AMR)
Takeda
Phase 2
36
Beijing, Guangdong, Nanning, Wuhan, Xi'an, Jinan, Chengdu, Hangzhou
2026-09-01
Not yet open
Dentate-Targeted Temporal Interference Stimulation for Post-Stroke Dysphagia
NCT07766668Deglutition Disorders, Ischemic Stroke
Zhejiang University
Not applicable
88
Hangzhou
2026-09-01
Recruiting
Drug-Drug Interaction Study of Vorolanib Tablets in Healthy Participants
NCT07809789DDI (Drug-Drug Interaction)
Betta Pharmaceuticals Co., Ltd.
Phase 1
36
Hangzhou
2026-09
Not yet open
SHR-A1811 Monotherapy or Sequential THPy as Neoadjuvant Therapy for Stage II-III HER2-Positive Breast Cancer
NCT07787338HER2-positive Breast Cancer
First Affiliated Hospital of Zhejiang University
Phase 2
80
Hangzhou
2026-09
Not yet open
A Study of BL-M08D1 in Patients With Recurrent or Metastatic Gynecological Malignancies and Other Solid Tumors
NCT07793825Gynecological Tumors, Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
90
Hangzhou
2026-09
Not yet open
A Phase I Study of HXN5003 in Healthy Participants and Patients With Moderate-to-Severe Atopic Dermatitis
NCT07801612Health Adult Subjects, Moderate-to-Severe Atopic Dermatitis
Helixon Biotechnology (Suzhou) Co., Ltd
Phase 1
68
Hangzhou
2026-09
Not yet open
Effectiveness of Artificial Intelligence-Assisted Colonoscopy for Adenoma Detection in Routine Clinical Practice : a Prospective Multicenter Randomized Trial
NCT07307547Colorectal Neoplasms, Colonic Polyp, Adenoma, Colorectal Cancer
Zhejiang University
Not applicable
3,300
Hangzhou
2026-09
Not yet open
Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)
NCT07767253Dermatitis, Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 3
246
Beijing, Guangzhou, Changsha, Hangzhou
2026-09
Recruiting
Drug-Drug Interaction Study of Befotertinib Capsules in Healthy Participants.
NCT07809815DDI (Drug-Drug Interaction)
Betta Pharmaceuticals Co., Ltd.
Phase 1
36
Hangzhou
2026-09
Not yet open
Study of SGC001 Injection for Predicted Severe Acute Pancreatitis to Assess Safety, Tolerability and Preliminary Efficacy
NCT07803965Acute Pancreatitis
Beijing Sungen Biomedical Technology Co., Ltd
Phase 2
129
Chengdu, Guizhou, Hangzhou, Hefei, Luoyang, Nanchang, Nanjing, Ningbo
2026-09
Not yet open
Spinal Cord Stimulation Combined With Motor Imagery Brain-Computer Interface for Chronic Post-Stroke Upper Limb Motor Dysfunction
NCT07686822Chronic Stroke
Zhejiang Provincial People's Hospital
Not applicable
66
Hangzhou
2026-09
Not yet open
Study of HXN6005 in Healthy Participants and Patients With Moderate-to-Severe Atopic Dermatitis
NCT07782476Health Adult Subjects, Atopic Dermatitis (AD)
Helixon Biotechnology (Suzhou) Co., Ltd
Phase 1/2
67
Hangzhou
2026-09
Recruiting
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
NCT07680764Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb
Phase 2
160
Beijing, Fuzhou, Wuhan, Nanjing, Shanghai, Chengdu, Hangzhou
2026-08-31
Not yet open
A Phase 2 Study of ABSK043 Combined With Osimertinib
NCT07710612Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive
Abbisko Therapeutics Co, Ltd
Phase 2
72
Guangzhou, Harbin, Wuhan, Shenyang, Shanghai, Taiyuan, Hangzhou
2026-08-31
Not yet open
High-Flow Nasal Cannula Oxygenation During Sedated Gastrointestinal Endoscopy in Patients With Chronic Obstructive Pulmonary Disease
NCT07791979Hypoxemia, Gastric Cancer (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD), Esophageal Cancer
Zhejiang University
Not applicable
90
Hangzhou
2026-08-29
Recruiting
Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy
NCT07347990Thrombotic Microangiopathy, Hematopoietic Stem Cell Transplantation (HSCT)
First Affiliated Hospital of Zhejiang University
Not applicable
30
Hangzhou
2026-08-25
Recruiting
A Study to Assess the Effectiveness and Safety of IPN10200 in Adult Chinese Participants With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
NCT07779252Moderate to Severe Glabellar Lines
Ipsen
Phase 3
160
Guangzhou, Changsha, Nanjing, Wuxi, Jingโ€™an, Chengdu, Hangzhou, Beijing
2026-08-25
Not yet open
An AI-Assisted Agentic System for Ultrasound Scanning and Diagnosis of Ovarian Lesions
NCT07801209Ovarian Mass, Adnexal Mass
Women's Hospital School Of Medicine Zhejiang University
Observational
250
Hangzhou, Shaoxing
2026-08-19
Recruiting
A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy Adults
NCT07749651Cutaneous Lupus Erythematosus(CLE)
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 1
50
Hangzhou
2026-08-19
Not yet open
A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer
NCT07736612Pancreatic Cancer, RAS Mutations or Amplifications
Zhejiang University
Phase 1/2
80
Hangzhou
2026-08-15
Not yet open
PTSD Risk Prediction Model for EICU Survivors
NCT07747415Post-traumatic Stress Disorder (PTSD)
Sir Run Run Shaw Hospital
Observational
800
Hangzhou
2026-08-15
Not yet open
Polygonatum Sibiricum Reduces Visceral Fat in Obese Adults
NCT07759323Visceral Obesity, Metabolic Syndrome
Zhejiang Provincial Tongde Hospital
Not applicable
66
Hangzhou
2026-08-15
Not yet open
The Biobank Integrating Longitudinal ERCP Within a Prospective Chronic Pancreatitis Cohort
NCT07770412Chronic Pancreatitis
First People's Hospital of Hangzhou
Observational
1,500
Hangzhou
2026-08-15
Not yet open
A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy
NCT07752264Refractory Immune-mediated Necrotizing Myopathy
Nanjing IASO Biotechnology Co., Ltd.
Phase 1/2
27
Beijing, Zhengzhou, Shanghai, Hangzhou
2026-08-15
Not yet open
Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An Umbrella Platform Study
NCT07729917Bile Duct Carcinoma, Cholangiocarcinoma
Zhejiang University
Phase 2
240
Hangzhou
2026-08-10
Not yet open
A Trial of Adacolumn on Cerebral Edema After Anterior Circulation Ischemic Stroke
NCT07386262Cerebral Edema, Ischemic Stroke, Acute, Malignant Cerebral Edema, Anterior Circulation Brain Infarction
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
10
Hangzhou
2026-08-10
Recruiting
Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
NCT06593392Pruritus, Chronic Kidney Diseases
Vifor Fresenius Medical Care Renal Pharma
Phase 2
18
Chengdu, Guangzhou, Hangzhou, Shanghai, Wuhan, Xi'an
2026-08-04
Recruiting
Metronomic Oral Paclitaxel Monotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose-Finding and Expansion Study
NCT07602907Advanced Breast Cancer, HER2-negative Breast Cancer
Zhejiang Cancer Hospital
Phase 2
73
Hangzhou
2026-08-04
Not yet open
Elemene Liposomes in Endometrial Cancer
NCT07738315Endometrial Carcinoma
Women's Hospital School Of Medicine Zhejiang University
Phase 2
212
Hangzhou
2026-08-01
Not yet open
Tofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar Pustulosis
NCT07530367Palmoplantar Pustulosis (PPP)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
135
Hangzhou
2026-08-01
Not yet open
DEC003M in Prostate Cancer
NCT07657806Advanced Prostate Cancer
Hangzhou DAC Biotechnology Co., Ltd.
Phase 1
110
Chengdu, Hangzhou, Chongqing
2026-08-01
Not yet open
Efficacy and Safety of the Visual Bronchial Blocker for Lung Isolation Surgery
NCT07644104Thoracic Surgery With One-lung Ventilation, Lung Isolation, Bronchial Blockage, Anesthesia
Zhejiang University
Not applicable
652
Hangzhou
2026-08-01
Not yet open
Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.
NCT07465718Wilson's Disease
Orphalan
Phase 3
38
Beijing, Hangzhou
2026-08
Not yet open
Research on AI Models for Predicting Breast Cancer Treatment Effectiveness to Guide Her-2 Targeted ADC Therapy
NCT07689929Breast Cancer
Zhejiang Cancer Hospital
Observational
900
Hangzhou
2026-08
Not yet open
Intranasal Dexmedetomidine and Perioperative Myocardial Injury
NCT07549282Coronary Heart Disease, Myocardial Injury, Myocardial Infarction, Dexmedetomidine
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
140
Hangzhou
2026-08
Not yet open
A Study of LAE118 as Monotherapy and in Combination With Antitumor Agents in Advanced Solid Tumors
NCT07787520Patients With Advanced Solid Tumors
Laekna Limited
Phase 1
150
Hefei, Beijing, Changchun, Shanghai, Hangzhou
2026-08
Not yet open
A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-Severe Ulcerative Colitis
NCT07758101Moderate to Severe Ulcerative Colitis
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 1
64
Hangzhou
2026-08
Not yet open
Effects of Agent-assisted, LLM-assisted and Traditional Workflows on Diagnosis and Management Planning at Admission
NCT07760051Clinical Decision Support Systems, Diagnostic Reasoning, Artificial Intelligence (AI)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
180
Hangzhou
2026-08
Recruiting
IBI363 Combined With Bevacizumab for Advanced Colorectal Cancer
NCT07722494Colorectal Cancer
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
550
Wuhan, Hangzhou
2026-07-31
Recruiting
First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors
NCT07700160Advanced Solid Tumors
VelaVigo Bio Inc
Phase 1/2
230
Beijing, Shanghai, Hangzhou
2026-07-30
Recruiting
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
NCT07725939Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
UCB Biopharma SRL
Phase 2
402
Beijing, Chengdu, Hangzhou, Nanchang
2026-07-27
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
NCT07497087Systemic Sclerosis
Boehringer Ingelheim
Phase 3
448
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Luoyang
2026-07-27
Active, closed
Dynamic Monitoring of Urinary Electrolytes
NCT07704450Healthy
Westlake University
Not applicable
40
Hangzhou
2026-07-20
Recruiting
SSGJ-705 Plus SSGJ-612 ยฑ Chemotherapy in Advanced HER2-Expressing Solid Tumors
NCT07646626Locally Advanced (Unresectable) or Metastatic Solid Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 2
150
Hangzhou
2026-07-17
Recruiting
A Phase I Trial of GW01-200 Tablets in Subjects With Advanced Tumors
NCT07629258Advanced Tumors
Groovy Medicine (Hangzhou) Ltd.
Phase 1
100
Beijing, Langfang, Hangzhou
2026-07-17
Active, closed
LEAF (Liver Tumor dEtection And classiFication AI)
NCT06859840Liver Malignancy
Zhejiang University
Not applicable
2,500
Hangzhou
2026-07-17
Recruiting
AI-Optimized Single-Feature Recognition Model for Heart Failure
NCT07667452Cardiac Sound, Heart Failure - NYHA II - IV
Vivalink
Observational
50
Hangzhou
2026-07-16
Recruiting
Single-Lead ECG Conduction Interval Algorithm
NCT07667465Conduction of Electrocardiogram
Vivalink
Observational
50
Hangzhou
2026-07-16
Recruiting
Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations
NCT07640295Metastatic Pancreatic Ductal Adenocarcinoma
Jacobio Pharmaceuticals Co., Ltd.
Phase 1/2
80
Beijing, Hangzhou, Changsha, Harbin, Nanjing, Shanghai, Taiyuan, Wuhan
2026-07-16
Recruiting
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
NCT07720284High-risk Muscle Invasive Urothelial Carcinoma
AstraZeneca
Phase 3
915
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hangzhou
2026-07-16
Recruiting
A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I
NCT07554924Spinal Muscular Atrophy 1
Lanyue Biotech (Hangzhou) Co., Ltd.
Phase 1/2
11
Beijing, Shanghai, Hangzhou
2026-07-15
Recruiting
A Study of HLX18 vs. OPDIVOยฎ in Multiple Resected Solid Tumors
NCT07518043Esophageal and/or Cardia Cancer, Melanoma, Urothelial Carcinoma (UC)
Shanghai Henlius Biotech
Phase 1
174
Fuzhou, Hangzhou, Luoyang, Tianjin, Wenzhou, Wuhan, Xi'an
2026-07-15
Recruiting
A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia
NCT07695597Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase 2
240
Hangzhou
2026-07-15
Active, closed
Research and Application Evaluation of Accurate Pressure Ulcer Area Measurement Technology Based on AI Grid Intelligent Recognition: A Self-controlled Study
NCT07743385Pressure Ulcers, Pressure Injuries
Affiliated Hospital of Nantong University
Not applicable
100
Bengbu, Nantong, Hangzhou
2026-07-14
Recruiting
A Study on the Efficacy and Safety of TEER Combined With Electrical Cardioversion in Patients With Severe Mitral Regurgitation and Atrial Fibrillation
NCT07741383Atrial Fibrillation Mitral Valve Insufficiency
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
570
Hangzhou
2026-07-14
Recruiting
Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors
NCT07692841Healthy Hematopoietic Stem Cell Donor, Healthy Allogeneic Hematopoietic Stem Cell Donor
First Affiliated Hospital of Zhejiang University
Phase 3
560
Changsha, Hangzhou, Jinhua, Ningbo, Wenzhou
2026-07-10
Recruiting
Safety and Efficacy of Eculizumab in High-risk TA-TMA
NCT07707687Transplant-Associated Thrombotic Microangiopathy (TA-TMA)
First Affiliated Hospital of Zhejiang University
Phase 2
24
Changsha, Hangzhou, Jinhua, Ningbo, Wenzhou
2026-07-10
Recruiting
DAREONยฎ-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
NCT07544654Extrapulmonary Neuroendocrine Cancer (epNEC)
Boehringer Ingelheim
Phase 3
390
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou
2026-07-10
Recruiting
A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
NCT07600788Chronic Hepatitis B
Ausper Biopharma Co., Ltd.
Phase 1
32
Chongqing, Zhengzhou, Shanghai, Chengdu, Hangzhou
2026-07-09
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
NCT07662044Type 2 Diabetes Mellitus
AstraZeneca
Phase 3
800
Baotou, Binzhou, Cangzhou, Changsha, Chengdu, Ganzhou, Haikou, Hangzhou
2026-07-06
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
NCT07662135Type 2 Diabetes Mellitus, Type 2 Diabetes With Chronic Kidney Disease
AstraZeneca
Phase 3
900
Binzhou, Changsha, Chengdu, Hangzhou, Jinan, Liaocheng, Liuzhou, Luoyang
2026-07-06
Recruiting
The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature
NCT07614152Turner Syndrome
Xiamen Amoytop Biotech Co., Ltd.
Phase 3
84
Anyang, Beijing, Changsha, Chengdu, Chongqing, Dalian, Guangzhou, Hangzhou
2026-07-05
Recruiting
A Study of SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
NCT07660432Neoplasms, Malignant
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
472
Fuzhou, Zhengzhou, Changsha, Shenyang, Jinan, Hangzhou
2026-07-03
Not yet open
Efficacy and Mechanism of IPSRT for Bipolar II Disorder
NCT07654348Bipolar Disorder II
First Affiliated Hospital of Zhejiang University
Phase 2
216
Hangzhou
2026-07-01
Active, closed
China Dizziness and Vertigo Cohort Study ๏ผˆVERIDICAL STUDY๏ผ‰
NCT07778901Vertigo, Vestibular Diseases
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
6,000
Hangzhou
2026-07-01
Not yet open
Application of Multimodal Intervention in the Prevention of Postoperative Nausea and Vomiting After Gynecological Laparoscopic Surgery
NCT07631910Nausea and Vomiting, Postoperative
Sir Run Run Shaw Hospital
Not applicable
212
Hangzhou
2026-07-01
Rows per page Showing 1–100 of 1812
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/hangzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,812 of those studies with a site in Hangzhou.

How many clinical trials are recruiting in Hangzhou?

1,096 of the 1,812 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 300 have not yet opened recruitment, 372 are active but closed to new participants, and 44 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hangzhou), 1,812 studies
PhaseStudiesRecruitingShare
Not applicable35620319.6%
Phase 235120719.4%
Phase 332916218.2%
Observational29420116.2%
Phase 119313910.7%
Phase 1/2134897.4%
Phase 466373.6%
Phase EARLY_PHASE159403.3%
Phase 2/330181.7%

Most active sponsors

Lead sponsors with the most studies (Hangzhou)
Lead sponsorStudiesRecruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine373254
Zhejiang University10467
First Affiliated Hospital of Zhejiang University10373
AstraZeneca7624
Zhejiang Cancer Hospital6349
The Children's Hospital of Zhejiang University School of Medicine4221
Janssen Research & Development, LLC4117
Sir Run Run Shaw Hospital3821
Hoffmann-La Roche3110
Zhejiang Provincial People's Hospital3122
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.